Clinical Trial Update: Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia [Phase 4]

View source ↗

Summary

This document reports the completion and posted results of a Phase 4 trial evaluating an endocardial ablation catheter for treating ventricular tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Drugs mentioned

• Endocardial Ablation Catheter

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Ventricular Tachycardia | Phase 4 | Status: COMPLETED | Results posted: 2014-10-16